{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:14:52Z","timestamp":1791404092428,"version":"4.3.3"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7,1]]},"DOI":"10.1097\/qai.0b013e3181cc5481","type":"journal-article","created":{"date-parts":[[2010,5,28]],"date-time":"2010-05-28T05:41:41Z","timestamp":1275025301000},"page":"290-296","source":"Crossref","is-referenced-by-count":49,"title":["Increased All-Cause and Cancer Mortality in HTLV-II Infection"],"prefix":"10.1097","volume":"54","author":[{"given":"Hope H","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanna","family":"Kaidarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Garratty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan W","family":"Gibble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce H","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Ziman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy L","family":"Fridey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A","family":"Sacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210131","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1128\/JCM.01249-08","article-title":"New insights into prevalence, genetic diversity, and proviral load of human T-cell leukemia virus types 1 and 2 in pregnant women in Gabon in equatorial central Africa.","volume":"46","author":"Etenna","year":"2008","journal-title":"J Clin Microbiol"},{"key":"R2-9-20210131","first-page":"23","article-title":"Trends in the seroprevalence of HTLV-1 in Japanese blood donors in Nagasaki Prefecture, 2000-2006.","volume":"23","author":"Iwanaga","year":"2009","journal-title":"Int J Hematol"},{"key":"R3-9-20210131","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4269\/ajtmh.1999.60.146","article-title":"Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru.","volume":"60","author":"Gotuzzo","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"R4-9-20210131","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1038\/sj.onc.1208971","article-title":"Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2.","volume":"24","author":"Feuer","year":"2005","journal-title":"Oncogene"},{"key":"R5-9-20210131","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1212\/01.WNL.0000096011.92542.DA","article-title":"Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study.","volume":"61","author":"Orland","year":"2003","journal-title":"Neurology"},{"key":"R6-9-20210131","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3201\/eid1001.020714","article-title":"Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection.","volume":"10","author":"Murphy","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"R7-9-20210131","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1742-4690-4-85","article-title":"Mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in a middle-aged and older population in Guinea-Bissau.","volume":"4","author":"Holmgren","year":"2007","journal-title":"Retrovirology"},{"key":"R8-9-20210131","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1023\/B:CACO.0000003853.82298.96","article-title":"Human T-lymphotropic virus type-I infection, survival and cancer risk in southwestern Japan: a prospective cohort study.","volume":"14","author":"Arisawa","year":"2003","journal-title":"Cancer Causes Control"},{"key":"R9-9-20210131","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1349-7006.1998.tb00631.x","article-title":"Human T-lymphotropic virus type-I infection, antibody titers and cause-specific mortality among atomic-bomb survivors.","volume":"89","author":"Arisawa","year":"1998","journal-title":"Jpn J Cancer Res"},{"key":"R10-9-20210131","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00042560-199708150-00010","article-title":"Decreased survival of HTLV-I carriers in leprosy patients from the Democratic Republic of the Congo: a historical prospective study.","volume":"15","author":"Lechat","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R11-9-20210131","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-4690-1-4","article-title":"Increased mortality associated with HTLV-II infection in blood donors: a prospective cohort study.","volume":"1","author":"Orland","year":"2004","journal-title":"Retrovirology"},{"key":"R12-9-20210131","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/00002030-200107060-00012","article-title":"Cause-specific mortality associated with HIV and HTLV-II infections among injecting drug users in the USA.","volume":"15","author":"Goedert","year":"2001","journal-title":"AIDS"},{"key":"R13-9-20210131","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/infdis\/174.2.309","article-title":"An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users.","volume":"174","author":"Hershow","year":"1996","journal-title":"J Infect Dis"},{"key":"R14-9-20210131","first-page":"1228","article-title":"HTLV-II\/HIV-1 coinfection and risk for progression to AIDS among intravenous drug users.","volume":"6","author":"Visconti","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R15-9-20210131","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF01719304","article-title":"Human T-cell leukemia virus type II infection among high risk groups and its influence on HIV-1 disease progression.","volume":"11","author":"Giacomo","year":"1995","journal-title":"Eur J Epidemiol"},{"key":"R16-9-20210131","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1086\/514143","article-title":"Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group.","volume":"176","author":"Murphy","year":"1997","journal-title":"J Infect Dis"},{"key":"R17-9-20210131","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-148-10-200805200-00005","article-title":"Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.","volume":"148","author":"Patel","year":"2008","journal-title":"Ann Intern Med"},{"key":"R18-9-20210131","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0959-8049(01)00120-4","article-title":"Epidemiology of AIDS-related tumours in developed and developing countries.","volume":"37","author":"Dal Maso","year":"2001","journal-title":"Eur J Cancer"},{"key":"R19-9-20210131","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens-Part B: biological agents.","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"R20-9-20210131","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4269\/ajtmh.2006.74.246","article-title":"Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.","volume":"74","author":"Hirata","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"R21-9-20210131","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/CVI.13.5.547-552.2006","article-title":"Peripheral blood mononuclear cells from individuals infected with human T-cell lymphotropic virus type 1 have a reduced capacity to respond to recall antigens.","volume":"13","author":"Mascarenhas","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"R22-9-20210131","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1182\/blood-2008-05-155960","article-title":"Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection.","volume":"112","author":"Bartman","year":"2008","journal-title":"Blood"},{"key":"R23-9-20210131","first-page":"1199","article-title":"Spontaneous lymphocyte proliferation in vitro characterizes both HTLV-I and HTLV-II infection.","volume":"3","author":"Prince","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R24-9-20210131","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1086\/315177","article-title":"A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan.","volume":"181","author":"Boschi-Pinto","year":"2000","journal-title":"J Infect Dis"},{"key":"R25-9-20210131","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1099\/vir.0.19334-0","article-title":"The immune control and cell-to-cell spread of human T-lymphotropic virus type 1.","volume":"84","author":"Bangham","year":"2003","journal-title":"J Gen Virol"},{"key":"R26-9-20210131","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00045415-200207000-00004","article-title":"Role of infection in atherosclerosis and coronary artery disease: a new therapeutic target?","volume":"10","author":"Frishman","year":"2002","journal-title":"Cardiol Rev"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201007010-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:24:39Z","timestamp":1786040679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201007010-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,1]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181cc5481","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7,1]]}}}